Drug intelligence / Profile preview

nacystelyn

Development stage
Phase 2
Lead developer
SMB Laboratories
Modality
Small Molecules
Administration
Inhalation
01

Overview

Nacystelyn is a lysine salt of N-acetylcysteine (NAC) developed by Laboratoires S.M.B. as a pH-neutral mucolytic and antioxidant agent. Unlike standard N-acetylcysteine, which is acidic, Nacystelyn is formulated to have a physiological pH (approximately 7.4), making it better tolerated for administration via inhalation as a dry powder or nebulized solution. Its primary mechanism of action involves the cleavage of disulfide bonds in mucoproteins, which reduces the viscosity and elasticity of bronchial secretions, thereby facilitating airway clearance. Additionally, it acts as a potent antioxidant by directly scavenging reactive oxygen species (ROS) and serving as a precursor for the synthesis of intracellular glutathione. While primarily investigated for respiratory conditions such as cystic fibrosis and chronic obstructive pulmonary disease (COPD), Nacystelyn has also been evaluated in Phase 2 clinical trials for obstructive sleep apnea (OSA) to address systemic oxidative stress and improve sleep parameters.

Brand names
Nacystelyn
Other names
N-acetyl-L-cysteine lysine saltLysine acetylcysteinateN-acetylcysteine lysine
02

Targets

MUC2 (Mucin-2)

Beyond the preview

Go deeper on nacystelyn.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nacystelyn.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call